DEERFIELD, Ill., Aug. 18, 2011 /PRNewswire/ -- A national analysis conducted by Sperling's BestPlaces and sponsored by Takeda Pharmaceuticals North America, Inc., identified Columbus, Ohio, as one of the nation's Hypertension Hot Spots, or cities that have hypertension risk factors and complications. The identification of the Hypertension Hot Spots is part of a larger Takeda-sponsored ...

A national analysis conducted by Sperling's BestPlaces and sponsored by Takeda Pharmaceuticals North America, Inc., identified Columbus, Ohio, as one of the nation's Hypertension Hot Spots, or cities that have hypertension risk factors and complications.

A new study shows the prevalence of gout in the United States has risen over the last twenty years and now affects 8.3 million Americans. Prevalence of increased uric acid levels (hyperuricemia) also rose, affecting 43.3 million adults in the U.S. Greater frequency of obesity and hypertension may be associated with the jump in prevalence rates, according to the findings.

Washington, July 10 (ANI): Hypertension is a major public health problem for blacks who live in the United States and the rate of medication adherence is unacceptably low in blacks as compared to whites, according to an expert.

Drug-maker Lupin Ltd said on Wednesday that it has got an approval from the regulator United States Food and Drugs Administration (USFDA) to manufacture and sell its generic version of hypertension drug Amlodipine/Benazepril.